Open navigation
Search

Intellectual Property

Latest

  • EU Pharmaceutical Package: what the Council’s revised texts mean for companies
    02 Oct 2026 8 min read
  • Joining the Dots – Part 4: Deadlines announced
    01 Oct 2026 4 min read
  • CJEU rules on when the ‘due cause’ defence falls flat (pack)
    23 Sep 2026 5 min read
  • A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)
    21 Aug 2026 7 min read
  • EU Pharma Package: Regulatory data and market protection
    14 Aug 2026 13 min read
  • EU Pharmaceutical Package: No Reset for Parallel Imports
    05 Aug 2026 10 min read
  • How the EU Pharma Package will reshape orphan drug regulation
    28 Jul 2026 8 min read
  • Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting
    23 Jul 2026 6 min read
  • The extension of the Bolar exemption in the EU Pharma Package
    21 Jul 2026 8 min read
  • Streaming, bitstreams and patent exhaustion: when VDP licensing demands go too far
    21 Jul 2026 12 min read
  • Encoder claims and standard essentiality: why categorical exclusions miss the mark
    16 Jul 2026 9 min read
  • Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package
    15 Jul 2026 7 min read
  • UK Clinical Trial Transparency and Patent Strategy
    13 Jul 2026 12 min read

CMS Adonnino Ascoli & Cavasola Scamoni prides itself to be a true partner to growing companies and enterprises, with the aim to most effectively leverage their intellectual assets. The strength of our team relies in the capacity of executing strategic intellectual property litigation, enforcing IP rights and defending against claims of infringement. The team can draw upon a strong team of professionals which have the experience and resources to provide our clients with the best available representation in intellectual property cases. We regularly litigate intellectual property issues in general including: patent, copyright, trade secret, and trademark litigation. Our intellectual property team aims to help our clients establish a competitive position for the future, and ultimately, provide them with value for their intellectual assets.

Intellectual Property Insights

EU Pharmaceutical Package: what the Council’s revised texts mean for companies

EU Pharmaceutical Package: what the Council’s revised texts mean for companies

02 Oct 2026 8 min read
Joining the Dots – Part 4: Deadlines announced

Joining the Dots – Part 4: Deadlines announced

01 Oct 2026 4 min read
CJEU rules on when the ‘due cause’ defence falls flat (pack)

CJEU rules on when the ‘due cause’ defence falls flat (pack)

23 Sep 2026 5 min read
A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)

A complex question: defining the SPC product in Accord v Novartis [2026] EWHC 2127 (Pat)

21 Aug 2026 7 min read
EU Pharma Package: Regulatory data and market protection

EU Pharma Package: Regulatory data and market protection

14 Aug 2026 13 min read
EU Pharmaceutical Package: No Reset for Parallel Imports

EU Pharmaceutical Package: No Reset for Parallel Imports

05 Aug 2026 10 min read
How the EU Pharma Package will reshape orphan drug regulation

How the EU Pharma Package will reshape orphan drug regulation

28 Jul 2026 8 min read
Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting

Geo-Blocking, VPNs and Territorial Reach – the CJEU’s Ruling in Anne Frank Fonds v Anne Frank Stichting

23 Jul 2026 6 min read

Events

  • 10 Sep 2026 - 04 Nov 2026
  • 30 Sep 2026 - 19 Nov 2026

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,400+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top
Warning: Fraudulent emails and messages
Opens in new window